| 0.1501 Delayed Data As of Feb 27 |  0.0001 / +0.07%Today’s Change | 0.05 Today|||52-Week Range 0.61 | +49.50% Year-to-Date |
| Previous close | 0.15 |
| Today’s open | 0.14 |
| Day’s range | -- - -- |
| Volume | 29,371 |
| Average volume (3 months) | 149,062 |
| Market cap | $5.6M |
| Dividend yield | -- |
| Earnings growth (last year) | +84.82% |
| Earnings growth (this year) | -79.49% |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | -98.55% |
| P/E ratio | NM |
| Price/Sales | 21.34 |
| Price/Book | -- |
| No competitors data available. |
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $1.4M |
| Annual profit (last year) | -$14.4M |
| Net profit margin | -1,053.62% |
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Director Richard M. Brenner |
President J. Weston Rose |
Corporate headquarters Cupertino, California |
